Studieoverzicht

 
 
  2017-02 PERIDENO       Closed       Adjuvant       HER2-, any HR       Postmenopausal  
  2010-02 STOP&GO       Closed       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal  
  2006-06 ATX       Closed       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal